Consensus Statement on Inpatient Use of Continuous Glucose Monitoring

Journal of Diabetes Science and Technology

Volumn 11, Issue 5, 2017, Pages 1036-1044

  Wallia, Amisha ^a   Umpierrez, Guillermo E ^b   Rushakoff, Robert J ^c   Klonoff, David C ^d   Rubin, Daniel J ^e   Hill Golden, Sherita ^f   Cook, Curtiss B ^g,h   Thompson, Bithika ^h  

^a NORTHWESTERN UNIVERSITY   (United States)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Mills Peninsula Health Services   (United States)

^e TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g ARIZONA STATE UNIVERSITY   (United States)

^h MAYO CLINIC   (United States)

Author keywords

continuous glucose monitor; diabetes; glucose; hospital; hypoglycemia; inpatient

Indexed keywords

PARACETAMOL;

ARTICLE; BLOOD GLUCOSE MONITORING; CAPILLARY FLOW; CLINICAL OUTCOME; DIABETES MELLITUS; FOLLOW UP; GLYCEMIC CONTROL; HOSPITAL PATIENT; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; INTENSIVE CARE UNIT; MORTALITY RATE; TISSUE PERFUSION; ANALYSIS; BLOOD; CONSENSUS DEVELOPMENT; GLUCOSE BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; PROCEDURES;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; HUMANS; HYPOGLYCEMIA; INPATIENTS;

EID: 85028656362     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/1932296817706151     Document Type: Article

References (44)

1. Wallia A, Umpierrez GE, Nasraway SA, Klonoff DC, PRIDE Investigators. round table discussion on inpatient use of continuous glucose monitoring at the international hospital diabetes meeting. J Diabetes Sci Technol. 2016; 10 (5): 1174-1181. doi: 10.1177/1932296816656380.
2. US Food and Drug Administration. FDA expands indication for continuous glucose monitoring system, first to replace fingerstick testing for diabetes treatment decisions. 2016. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm534056.htm. Accessed January 9, 2017.
3. Rice MJ, Coursin DB., Continuous measurement of glucose: facts and challenges. Anesthesiology. 2012; 116 (1): 199-204.
4. Gottschalk A, Welp HA, Leser L, Lanckohr C, Wempe C, Ellger B., Continuous glucose monitoring in patients undergoing extracorporeal ventricular assist therapy. PLOS ONE. 2016; 11 (3): e0148778.
5. Preiser JC, Chase JG, Hovorka R, et al. Glucose control in the ICU: a continuing story. J Diabetes Sci Technol. 2016; 10 (6): 1372-1381.
6. van Steen SC, Rijkenberg S, Limpens J, et al. The clinical benefits and accuracy of continuous glucose monitoring systems in critically Ill patients-a systematic scoping review. Sensors (Basel). 2017; 17 (1).
7. De Block C, Manuel-Y-Keenoy B, Van Gaal L, Rogiers P,. Intensive insulin therapy in the intensive care unit: assessment by continuous glucose monitoring. Diabetes Care. 2006; 29 (8): 1750-1756.
8. Holzinger U, Warszawska J, Kitzberger R, Herkner H, Metnitz PG, Madl C., Impact of shock requiring norepinephrine on the accuracy and reliability of subcutaneous continuous glucose monitoring. Intensive Care Med. 2009; 35 (8): 1383-1389. doi: 10.1007/s00134-009-1471-y.
9. Rabiee A, Andreasik V, Abu-Hamdah R, et al. Numerical and clinical accuracy of a continuous glucose monitoring system during intravenous insulin therapy in the surgical and burn intensive care units. Diabetes Sci Technol. 2009; 3 (4): 951-959.
10. Holzinger U, Warszawska J, Kitzberger R, et al. Real-time continuous glucose monitoring in critically ill patients: a prospective randomized trial. Diabetes Care. 2010; 33 (3): 467-472.
11. Kopecky P, Mraz M, Blaha J, et al. The use of continuous glucose monitoring combined with computer-based eMPC algorithm for tight glucose control in cardiosurgical ICU. Biomed Res Int. 2013; 2013: 186439.
12. Boom DT, Sechterberger MK, Rijkenberg S, et al. Insulin treatment guided by subcutaneous continuous glucose monitoring compared to frequent point-of-care measurement in critically ill patients: a randomized controlled trial. Crit Care. 2014; 18 (4): 453.
13. Kosiborod M, Gottlieb RK, Sekella JA, et al. Performance of the Medtronic Sentrino continuous glucose management (CGM) system in the cardiac intensive care unit. BMJ Open Diabetes Res Care. 2014; 2 (1): e000037.
14. Leelarathna L, English SW, Thabit H, et al. Accuracy of subcutaneous continuous glucose monitoring in critically ill adults: improved sensor performance with enhanced calibrations. Diabetes Technol Ther. 2014; 16 (2): 97-101.
15. Punke MA, Decker C, Wodack K, Reuter DA, Kluge S., Continuous glucose monitoring on the ICU using a subcutaneous sensor. Med Klin Intensivmed Notfmed. 2015; 110 (5): 360-363.
16. Umbrello M, Salice V, Spanu P, et al. Performance assessment of a glucose control protocol in septic patients with an automated intermittent plasma glucose monitoring device. Clin Nutr. 2014; 33 (5): 867-871. doi: 10.1016/j.clnu.2013.10.007.
17. Sechterberger MK, van der Voort PH, Strasma PJ, DeVries JH., Accuracy of intra-arterial and subcutaneous continuous glucose monitoring in postoperative cardiac surgery patients in the ICU. J Diabetes Sci Technol. 2015; 9 (3): 663-667.
18. Nohra E, Buckman S, Bochicchio K, et al. Results of a near continuous glucose monitoring technology in surgical intensive care and trauma. Contemp Clin Trials. 2016; 50: 1-4. doi: 10.1016/j.cct.2016.07.007.
19. Wollersheim T, Engelhardt LJ, Pachulla J, et al. Accuracy, reliability, feasibility and nurse acceptance of a subcutaneous continuous glucose management system in critically ill patients: a prospective clinical trial. Ann Intensive Care. 2016; 6 (1): 70.
20. Schierenbeck F, Franco-Cereceda A, Liska J., Accuracy of 2 different continuous glucose monitoring systems in patients undergoing cardiac surgery. J Diabetes Sci Technol. 2017; 11 (1): 108-116.
21. Bridges BC, Preissig CM, Maher KO, Rigby MR., Continuous glucose monitors prove highly accurate in critically ill children. Crit Care. 2010; 14 (5): R176.
22. Prabhudesai S, Kanjani A, Bhagat I, Ravikumar KG, Ramachandran B., Accuracy of a real-time continuous glucose monitoring system in children with septic shock: a pilot study. Indian J Crit Care Med. 2015; 19 (11): 642-647.
23. Clarke WL, Kovatchev B., Continuous glucose sensors: continuing questions about clinical accuracy. J Diabetes Sci Technol. 2007; 1 (5): 669-675.
24. Dungan K, Chapman J, Braithwaite SS, Buse J., Glucose measurement: confounding issues in setting targets for inpatient management. Diabetes Care. 2007; 30 (2): 403-409.
25. Klonoff DC., Cybersecurity standard for connected diabetes devices. J Diabetes Sci Technol. 2016; 3 (10): 623-626.
26. Finfer S, Heritier S, Committee NSM, Committee SSE. The NICE-SUGAR (Normoglycaemia in Intensive Care Evaluation and Survival Using Glucose Algorithm Regulation) study: statistical analysis plan. Crit Care Resusc. 2009; 11 (1): 46-57.
27. Umpierrez GE, Hellman R, Korytkowski MT, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012; 97 (1): 16-38.
28. Rodbard HW, Jellinger PS, Davidson JA, et al. Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. Endocr Pract. 2009; 15 (6): 540-559.
29. Jacobi J, Bircher N, Krinsley J, et al. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med. 2012; 40 (12): 3251-3276.
30. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001; 345 (19): 1359-1367.
31. NICE-SUGAR Study Investigators, Finder S, Chittack DR, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009; 360 (13): 1283-1297. doi: 10.1056/NEJMoa0810625.
32. Wernerman J, Desaive T, Finfer S, et al. Continuous glucose control in the ICU: report of a 2013 round table meeting. Crit Care. 2014; 18 (3): 226.
33. Mahmoodpoor A, Hamishehkar H, Beigmohammadi M, et al. Predisposing factors for hypoglycemia and its relation with mortality in critically Ill patients undergoing insulin therapy in an intensive care unit. Anesth Pain Med. 2016; 6 (1): e33849. doi: 10.5812/aapm.33849.
34. Aragon D., Evaluation of nursing work effort and perceptions about blood glucose testing in tight glycemic control. Am J Crit Care. 2006; 15 (4): 370-377.
35. Bach LA, Ekinci E, Engler D, et al. The high burden of inpatient diabetes mellitus: the Melbourne Public Hospitals Diabetes Inpatient Audit. Med J Aust. 2014; 201 (6): 334-338.
36. Burt MG, Roberts GW, Aguilar-Loza NR, Stranks SN., Brief report: Comparison of continuous glucose monitoring and finger-prick blood glucose levels in hospitalized patients administered basal-bolus insulin. Diabetes Technol Ther. 2013; 15 (3): 241-245. doi: 10.1089/dia.2012.0282.
37. Rodríguez LM, Knight RJ, Heptulla RA., Continuous glucose monitoring in subjects after simultaneous pancreas-kidney and kidney-alone transplantation. Diabetes Technol Ther. 2010; 12 (5): 347-351. doi: 10.1089/dia.2009.0157.
38. Gómez AM, Umpierrez GE, Muñoz OM, et al. Continuous glucose monitoring versus capillary point-of-care testing for inpatient glycemic control in type 2 diabetes patients hospitalized in the general ward and treated with a basal bolus insulin regimen. J Diabetes Sci Technol. 2015; 10 (2): 325-329. doi: 10.1177/1932296815602905.
39. Thomas F, Signal M, Harris DL, et al. Continuous glucose monitoring in newborn infants: how do errors in calibration measurements affect detected hypoglycemia. J Diabetes Sci Technol. 2014; 8 (3): 543-550.
40. Wong JC, Foster NC, Maahs DM, et al. Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry. Diabetes Care. 2014; 37 (10): 2702-2709.
41. Chamberlain JJ, Dopita D, Gilgen E, Neuman A., Impact of frequent and persistent use of continuous glucose monitoring (CGM) on hypoglycemia fear, frequency of emergency medical treatment, and SMBG frequency after one year. J Diabetes Sci Technol. 2016; 10 (2): 383-388.
42. Polonsky WH, Peters AL, Hessler D., The impact of real-time continuous glucose monitoring in patients 65 years and older. J Diabetes Sci Technol. 2016; 10 (4): 892-897.
43. Dungan KM, Han W, Miele A, Zeidan T, Weiland K., Determinants of the accuracy of continuous glucose monitoring in non-critically ill patients with heart failure or severe hyperglycemia. J Diabetes Sci Technol. 2012; 6 (4): 884-891.
44. US Food and Drug Administration. FDA approves first automated insulin delivery device for type 1 diabetes. 2016. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm522974.htm. Accessed January 9, 2017.